| Previous Close | 125.05 |
| Open | 125.45 |
| Bid | 125.59 x 1300 |
| Ask | 125.60 x 200 |
| Day's Range | 125.37 - 125.69 |
| 52 Week Range | 101.51 - 126.35 |
| Volume | 449,253 |
| Avg. Volume | 2,182,146 |
| Net Assets | 574.64B |
| NAV | 123.86 |
| PE Ratio (TTM) | N/A |
| Yield | 1.84% |
| YTD Return | 7.88% |
| Beta (3y) | 1.02 |
| Expense Ratio (net) | 0.04% |
| Inception Date | 2001-05-24 |
- Market Realist•1 hour ago
FDA Approves Edwards Lifesciences’ Sapien 3 Valve for Expanded Indication
On June 5, 2017, Edwards Lifesciences (EW) received FDA approval for its Sapien 3 transcatheter heart valve for aortic and mitral valve-in-valve procedures.
- Investopedia•4 hours ago
How to Start Saving For Retirement
If you establish these money-saving habits and patiently allow your wealth to build, you will be taking some huge steps forward in making your financial future more secure.
- Market Realist•3 days ago
ISRG Expands across Low-Cost Markets with Da Vinci X Launch
On May 30, 2017, Intuitive Surgical (ISRG) announced that it received FDA (US Food and Drug Administration) approval of its new da Vinci X robotic surgical system.